Brain tumor
Glioblastoma multiforme (GBM) is the most aggressive (grade IV) and most common form of a malignant brain tumor. Even when aggressive multimodality therapy consisting of radiotherapy, chemotherapy, and surgical excision is used, median survival is only 12–17 months. Standard therapy for glioblastoma multiforme consists of maximal surgical resection of the tumor, followed by radiotherapy between two and four weeks after the surgical procedure to remove the cancer, then by chemotherapy, such as temozolomide. Most patients with glioblastoma take a corticosteroid, typically dexamethasone, during their illness to relieve symptoms. Experimental treatments include targeted therapy, gamma knife radiosurgery, boron neutron capture therapy and gene therapy.
Radiation effects from the Fukushima Daiichi nuclear disaster
Thyroid cancer is one of the most survivable cancers, with an approximate 94% survival rate after first diagnosis, and that rate increases to a 100% survival rate with catching it early. For example, from 1989 to 2005, an excess of 4000 children and adolescent cases of thyroid cancer were observed in those who lived around Chernobyl; of these 4000 people, nine have died so far, a 99% survival rate.